Ce diaporama a bien été signalé.
Le téléchargement de votre SlideShare est en cours. ×

"Empowering Consumer with Smart Devices and Smart Data for Proactive ‘Health Care’" - Maryam Ziaei (Founder/CEO, iSono Health)

Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité

Consultez-les par la suite

1 sur 72 Publicité

"Empowering Consumer with Smart Devices and Smart Data for Proactive ‘Health Care’" - Maryam Ziaei (Founder/CEO, iSono Health)

Télécharger pour lire hors ligne

"Empowering Consumer with Smart Devices and Smart Data for Proactive ‘Health Care’" - Maryam Ziaei (Founder/CEO, iSono Health)

Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.

For more information including details of subsequent events, please visit http://hyperwellbeing.com

The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.

WaaS newsletter sign-up http://eepurl.com/b71fdr

@hyperwellbeing

"Empowering Consumer with Smart Devices and Smart Data for Proactive ‘Health Care’" - Maryam Ziaei (Founder/CEO, iSono Health)

Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.

For more information including details of subsequent events, please visit http://hyperwellbeing.com

The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.

WaaS newsletter sign-up http://eepurl.com/b71fdr

@hyperwellbeing

Publicité
Publicité

Plus De Contenu Connexe

Diaporamas pour vous (20)

Publicité

Similaire à "Empowering Consumer with Smart Devices and Smart Data for Proactive ‘Health Care’" - Maryam Ziaei (Founder/CEO, iSono Health) (20)

Plus par Hyper Wellbeing (18)

Publicité

"Empowering Consumer with Smart Devices and Smart Data for Proactive ‘Health Care’" - Maryam Ziaei (Founder/CEO, iSono Health)

  1. 1. Democratizing Healthcare
  2. 2. Patient- Centered Healthcar e HOSPITA L HOME Personalized What’s the best care for my needs? Predictive What health trends that are likely to develop? Proactive Who’s at risk? Who needs to be informed? Preventative What actions can I take now to prevent disease?
  3. 3. Proactive Personalized Health: Move to LEFT Health Status 80% of Cost from 20% of Population
  4. 4. Personalized Medical Home Smart Sensing Intelligent Information Management Effective Interfaces Putting the patient at the center of their health system Family & Friends Healthcare Providers Web Repositories Healthcare Institutions Researchers
  5. 5. Smart Devices Connected Systems End-to-End Analytics Patient-Centric Home Health Smart Big Data Actionable Insights
  6. 6. Smart Devices Connected Systems End-to-End Analytics Smart Sensors for Every Sense
  7. 7. Smart Devices • Non-invasive wearable sensors • Personal biosensors • Environmental sensors • New data streams + machine learning = “New vital signs”
  8. 8. Smart DevicesSmart Devices
  9. 9. Smart DevicesSmart Devices
  10. 10. Smart Devices
  11. 11. Smart Devices
  12. 12. Consumer Technologies Social Media Technologies Internet Technologies Visualisation Technologies Learning Technologies Enabling Technologies From glasses to wearables VLE PLE Collective intelligence Collaborative environments Next gen batteries Wireless power Tablet Quantified self 3D printing Information Visualisation Drivers of Disruption in Healthcare
  13. 13. Smart Phone
  14. 14. 3D Printing
  15. 15. Machine Learning Tags Abnormalities Human-Centered Design Adoption + Adherence Human Nature Admires Complexity but Rewards Simplicity.
  16. 16. Effective Interfaces • Multimodal – GUI, touch, gesture, speech, … • Mobile – Portable, networked, wearable • Intuitive – Easy to learn, use, maintain • Adaptive • Proactive
  17. 17. Machine Learning Tags Abnormalities Security Privacy Compliance
  18. 18. Machine Learning Tags Abnormalities > 400 Million Units by 2020
  19. 19. Machine Learning Tags Abnormalities Patient Generated Data  Big Data
  20. 20. Intelligent Information Management • Longitudinal data – Personal baseline – Detect trends & deviations from norm • Personal health records – Privacy – Sharing – Anonymous aggregation • Patient-centered decision support
  21. 21. Data Aggregation and Analytics
  22. 22. Artificial Intelligence for Predictive Healthcare
  23. 23. From Data to Decisions
  24. 24. REACTIVE  PROACTIVE SPORADIC  CONTINOUS
  25. 25. Machine Learning Tags Abnormalities EARLY ENAGEMENT = SUCCESS in Healthcare
  26. 26. 28
  27. 27. Regular Accessible Breast Health Monitoring
  28. 28. 1 in 8 women WILL BE DIAGNOSED WITH BREAST CANCER
  29. 29. Machine Learning Tags Abnormalities EARLY DETECTION = 99% SURVIVAL
  30. 30. 1 in 3 BREAST CANCERS IS MISSED
  31. 31. 47% of women have dense breasts BUT Mammogram misses tumors in dense breasts Breast Cancer screening is sporadic, inaccessible, and expensive High risk women need more regular screening
  32. 32. Current Breast Ultrasound Sources: American Cancer Society, American College of Radiology Image Quality is Operator Dependent False Positive
  33. 33. Cost ~ 5-10K SonoSite PhilipsGE VSCAN GE Siemens Cost ~ $200-400K 35.7% More Cancer Detected with Automated Breast Ultrasound * Point-of-Care Automated
  34. 34. 3D ULTRASOUNDWEARABLE MOBILE APP Automated + Low-Cost 2 Patents
  35. 35. Machine Learning Tags Abnormalities
  36. 36. Machine Learning Detect Changes EARLY and Track Over Time
  37. 37. 2 Minutes Scan  No Radiation  Actionable Feedback
  38. 38. Clinical Study with 100 Women iSono GE
  39. 39. Early Adopters Market of $4B CAGR of 10.8% Pricing: $300/Device $20/User/M onth ARR US Market 8.6M Women at Very High Risk Total Addressable Market of $32B 102M Women over 30 in US
  40. 40. Early Stage Diagnosis $20K pp Late Stage Diagnosis $100-300K pp $18.5B Direct Cost of Breast Cancer + $14B Lost Productivity Per Year for self-insured employers and health insurance companies Why Would Payers Care?
  41. 41. 44 Regular and Accessible Breast Health Monitoring $32B Market
  42. 42. Personalized, Proactive Healthcare Better Health Better Care Better Value maryam@isonohealth.com
  43. 43. Making Sense of Big Data • Understanding human behavior from sensor data – Integrating vastly different kinds of data – Incorporating commonsense knowledge – Compute intensive methods for learning & inference • Embedded, mobile, and distributed systems – Data transport in dynamic, heterogeneous environments – Security and data sharing – Data / annotation / interpretation streams
  44. 44. 49 System Concept Personal Health Monitoring • Preventative Healthcare • Chronic Care Management • Post-surgery Monitoring • Borrow from the field of machine health monitoring – Identify the most minimally invasive ways to capture data – Mine collected data to identify personal baselines, data defined models and track changes – Identify patient preferences and create a system that gives a valuable user experience – Identify effective ways to share data with health care providers Measure • Cardiac function (ECG) • Respiration (Sound/ECG) • Activity (Accelerometry) Alivetec ECG & motionTouch screen mobile phone
  45. 45. Personal Health Management Assistant • Provide effective, intuitive access to information in Personal Health Record • True conversational interaction – UR Computer Science leading center of research on dialog systems – Not just canned responses: reasons about user model and dialog context • Target population: Heart failure patients following self-care guidelines – Collect information relevant to condition – Interpret with respect to self-care guidelines – Suggest appropriate course of action – Facilitate information sharing with doctors & family
  46. 46. Smart Sensors
  47. 47. Go-to-Market Strategy High Risk Women Surveillance Women over 30 Screening Channels & Partners • Women Healthcare Centers • BC Advocacy Groups • Genetic Testing/Counseling • Corporate Wellness • Mail-in-Subscription • Walk-in Health Clinics Breast Cancer Patient Monitoring • Breast Cancer Centers • BC Pharma
  48. 48. 1Billion Women need additional screening 50M Women at Very High Risk due to Family History or Genetics Every Year 1.7M New Cases of Breast Cancer Market Over 500,000 Breast Cancer Deaths/year
  49. 49. Competitive Landscape Portable Ultrasound Automated Ultrasound 35% More Cancers Detected Cost: $200K + Wearable Sensor Solutions Cost: $5-10K Disadvantage: Probe Operator Error
  50. 50. 1Billion Women over 30 in the World with Dense Breasts 50M Women at Very High Risk due to Family History or Genetics Every Year 1.7M New Cases of Breast Cancer Market Over 500,000 Breast Cancer Deaths/year
  51. 51. Early Adopters Market of $4B CAGR of 10.8% Pricing: $300/Device $20/User/M onth ARR US Market 8.6M Women at Very High Risk Total Addressable Market of $32B 102M Women over 30 in US
  52. 52. European Market Every Year 500,000 New Cases of Breast Cancer Over 140,000 Breast Cancer Deaths/year 14M Women at Very High Risk due to Family History or Genetics Early Adopters Market of $8B
  53. 53. Women with Dense Breasts Sporadic and Inaccessible Screening High Risk Women
  54. 54. Current Breast Cancer Screening Self Breast Exam Ineffective for small tumors Mammogram Low Sensitivity X-ray Radiation
  55. 55. 1Billion Women over 30 in the World with Dense Breasts 50M Women at Very High Risk due to Family History or Genetics Every Year 1.7M New Cases of Breast Cancer Global Market Over 500,000 Breast Cancer Deaths/year
  56. 56. Quantitative Ultrasound + Machine Learning • A multi-parameter longitudinal approach improves precision Grayscale Image Qualitative features • Shape • Contour • Shadow Raw RF signal Quantitative features • Power spectrum • Statistics • Frequency dependence Parametric Change Longitudinal features • Volume density • Cell death/growth • Tissue acoustic properties
  57. 57. FDA Regulatory Roadmap Research and Development Pre-Clinical Development Clinical Testing FDA 510(k) Approval Concept Design Control Design Iterations Repeatability Testing Submit 510(k) Package FDA Review & QuestionsPackaging & Labeling Biocompatability Repeatability Testing Electrical & Mechanical Testing Repeatability Testing IRB/IDE Approval Neo-adjuvant Chemo Trial 12weeks ~100 Patients Human Factor Study ~50-75 Users Efficacy Best Case Scenario: Class II 510(k) no clinical study • Predicate found already • Expected clearance 5-6mo • Need 50 users for usability Validation Development Worst Case Scenario: Class II 510(k) DeNovo - Expected clearance 10- 12mo - Need 100+ users for clinical Efficacy We’re Here
  58. 58. Screening Today Self Breast Exam Mammogram Insurance Covers >50 Ultrasound $500 MRI $ 2000
  59. 59. Go-to-market Timeline ✔ Q3 2015 ✔ ✔ Q1 Q2 Q3 Q4Q4 2016 ✔✔ 2017 ✔ Q1 Q2 2018
  60. 60. Partnerships iSono Health’s compact, low-cost, automated ultrasound system enables Remote Patient Monitoring for: Neoadjuvent Chemo Patients, BC Clinical Trials Tracking Response to Treatment Personalized Treatment Early Stage BC Patient Post-Lumpectomy Recurrence Monitoring Breast Conserving Surgeries High Risk Women with Family History, Genetics Surveillance Early Stage Detection Healthy Women with Dense Breasts Supplemental Screening False- Negative/Positive Reduction
  61. 61. Customer Validation In a national survey of 1000 women, 38% have responded favorably to purchasing our device "Amazing idea. Anything that can give anyone a more sound piece of mind or the ability to see something sooner is a great tool." "Please keep me informed of the details of this product." "I'm very excited about this being a viable option for preventative screening!" "I would be excited to have access to a device like this. I live in a rural area with little access to Healthcare. I have been diagnosed with BRCA1 mutated gene … this would help me be proactive." 68% of high-risk women self- reported as “very/extremely willing” to purchase our device
  62. 62. Device Machine LearningCloud iSono IP Strategy - Array Architecture Transducer Assembly - 3D Image Processing -Tag and Measure Breast Masses -Track changes over time - User Interface - Scan Analytics - Genetic + Scan Actionable
  63. 63. Cost ~ 5-10K Current Ultrasound Trends: Cheaper, Automated SonoSite PhilipsGE VSCAN MobiSante Image Quality is Operator DependentGE Invenia (Acquired U Systems) Siemens ACUSON S2000 SonoCine Cost ~ $200-400K 35.7% More Cancer Detected with Automated Breast Ultrasound* Compact Ultrasound Probe Systems Sources: MarketsandMarkets, Frost and Sullivan *http://www.fdanews.com/articles/164936-ge-healthcare-nabs-fda-approval-of-invenia-abus-breast-imaging-technology
  64. 64. How Does it Work? Comfortably wear the bra accessory. Attach scanner to ring on either breast. Open iSono app press “scan.” The scan completes in 1 minute. Attach device to the second ring on the other breast. Our software will process images and tag any changes. Physician receives your tagged images & sends you feedback via the app. The app will remind you of the next scan in 1 month.
  65. 65. Real Time Data Real Time Feedback Faster Return to Work Less time in hospital/healthcare facilities  reduced cost Post surgery monitoring

Notes de l'éditeur

  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • Opportunities with consumer-based home healthcare devices
    Connected devices
    Transform big data into information that delivers insights
    Simply user experience with Human-centered design

  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • Hi, I’m Maryam, co-founder of iSono health, we have developed a platform to empower every woman to take charge of their own health with a connected breast health monitoring platform
  • Our platform combined automated ultrasound technology with Artificial Intelligence and Cloud Computation to regularly monitoring and tracking breast health over time, for early detection of breast cancer.
  • When I was in college my friend Kelly was diagnosed with breast cancer. She wasn’t even 30…She was lucky her cancer was caught at early stage and after treatment now she’s healthy and has a kind. Every year 1.7 Million women get diagnosed globally with breast cancer, 500,000 here europe. Many of them are not as lucky.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • You might ask why? That’s because nearly half of women half dense tissues in their breast that makes mammogram ineffective. On the top right here you can see how a dense breast looks like in a mammogram, it effectively masks any small tumors.

    A great alternative to mammogram is Ultrasound. However ultrasound is not used today as screening tool, b/c it’s slow, images are operator dependent and has high false positives.

    Beyond that women who are at high risk of breast cancer due to family history or genetics need more regular screening but breast cancer screening today is only once a year, its expensive and inconvenient.
  • we are making a disruption by making it lower  cost and bring it in the hand of consumer
    Regular monitoring 
  • Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
     “Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
    The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.

    Around the World:
    Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
    Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
    Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
    Globally, breast cancer now represents one in four of all cancers in women. 
    Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. ​According to the World Cancer Research Fund International



  • Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
     “Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
    The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.

    Around the World:
    Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
    Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
    Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
    Globally, breast cancer now represents one in four of all cancers in women. 
    Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. ​According to the World Cancer Research Fund International



  • Breast Cancer has likely affected everyone in this room one way and another.
    We want to make sure no woman dies from breast cancer and put the power back into the hands of consumer.
    WE have the smart technology to do this
    Come see a demo and join us to save lives.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • 1 in 3 breast cancers are missed at early stage by current screening methods.
  • Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
     “Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
    The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.

    Around the World:
    Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
    Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
    Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
    Globally, breast cancer now represents one in four of all cancers in women. 
    Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. ​According to the World Cancer Research Fund International



  • Wearable medical devices defined in the strictest sense are devices with sensors attached to the body that detect and monitor changes in body signatures of various areas and organs. This report focuses on the various segments of wearable devices currently available in the market and also predicts the introduction of several innovative devices in the future.
    http://www.transparencymarketresearch.com/wearable-medical-devices.html
  • Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
     “Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
    The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.

    Around the World:
    Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
    Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
    Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
    Globally, breast cancer now represents one in four of all cancers in women. 
    Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. ​According to the World Cancer Research Fund International



  • Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
     “Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
    The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.

    Around the World:
    Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
    Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
    Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
    Globally, breast cancer now represents one in four of all cancers in women. 
    Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. ​According to the World Cancer Research Fund International



  • Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
     “Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
    The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.

    Around the World:
    Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
    Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
    Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
    Globally, breast cancer now represents one in four of all cancers in women. 
    Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. ​According to the World Cancer Research Fund International



  • You might ask why? That’s because screening is sporadic and inaccessible to millions of women worldwide. And among those who have access to screening, mammogram doesn’t work for half of women who have dense breasts due to to limitations of xray technology. Furthermore, women who have family history or genetically predisposed need even more frequent screening. These three groups of women consitute our different costumer segments.

    A great alternative to mammogram is Ultrasound. However ultrasound is not used today as screening tool, b/c it’s slow, images are operator dependent and has high false positives.

    Beyond that women who are at high risk of breast cancer due to family history or genetics need more regular screening but breast cancer screening today is only once a year, its expensive and inconvenient.
  • 1 in 8 women will be diagnosed with invasive breast cancer in their lifetime
    Every 3 minutes a woman is diasnosed with breast cancer
    Every 13 minutes a woman dies from breast cancer
    >400,000 Deaths per year from Breast Cancer
    Early detection can increase the 10 year survival rate to 97%

    Mammogram, which is the primary screening tool, cannot detect cancer in dense breast tissue (~50% of women)
    Insurance cover mammogram screening for women above 50
    Women with high risk have 60-80% chance of breast cancer  require regular monitoring
    If you have a first degree relative who was diagnosed with breast cancer your chances are two times higher. If you have two relatives who were diagnosed, your chances are 5x higher
    Some women with high risk such as Angelina Jolie resort to double-mastectomy
    Even with double mastectomy, you have to constantly monitor your breast/breast area as cancerous cell still can develop
  • Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
     “Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
    The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.

    Around the World:
    Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
    Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
    Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
    Globally, breast cancer now represents one in four of all cancers in women. 
    Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent. ​According to the World Cancer Research Fund International



  • 1 in 8 women will be diagnosed with invasive breast cancer in their lifetime
    Every 3 minutes a woman is diasnosed with breast cancer
    Every 13 minutes a woman dies from breast cancer
    >400,000 Deaths per year from Breast Cancer
    Early detection can increase the 10 year survival rate to 97%

    Mammogram, which is the primary screening tool, cannot detect cancer in dense breast tissue (~50% of women)
    Insurance cover mammogram screening for women above 50
    Women with high risk have 60-80% chance of breast cancer  require regular monitoring
    If you have a first degree relative who was diagnosed with breast cancer your chances are two times higher. If you have two relatives who were diagnosed, your chances are 5x higher
    Some women with high risk such as Angelina Jolie resort to double-mastectomy
    Even with double mastectomy, you have to constantly monitor your breast/breast area as cancerous cell still can develop
    ----- Meeting Notes (10/19/16 14:52) -----
    insurance
  • Change colors of arrows
  • 1 in 3 breast cancers are missed at early stage by current screening methods.

×